These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31551918)

  • 1. Editorial: Radiopharmaceuticals, Imaging Techniques and Clinical Applications in Neurodegenerative Diseases.
    Zuo C; Zhuang X; Heckemann RA; Peng F
    Front Neurol; 2019; 10():962. PubMed ID: 31551918
    [No Abstract]   [Full Text] [Related]  

  • 2. SPECT radiopharmaceuticals for dementia.
    Guidotti C; Farioli D; Gaeta MC; Giovannini E; Lazzeri P; Meniconi M; Ciarmiello A
    Curr Radiopharm; 2013 Dec; 6(4):192-207. PubMed ID: 24359135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New molecular targets for PET and SPECT imaging in neurodegenerative diseases.
    Benadiba M; Luurtsema G; Wichert-Ana L; Buchpigel CA; Busatto Filho G
    Braz J Psychiatry; 2012 Oct; 34 Suppl 2():S125-36. PubMed ID: 23429844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translational Multimodality Neuroimaging.
    Sharma S
    Curr Drug Targets; 2017; 18(9):1039-1050. PubMed ID: 28302035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Prospective Study Comparing
    Löfgren J; Mortensen J; Rasmussen SH; Madsen C; Loft A; Hansen AE; Oturai P; Jensen KE; Mørk ML; Reichkendler M; Højgaard L; Fischer BM
    J Nucl Med; 2017 Nov; 58(11):1778-1785. PubMed ID: 28798033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases.
    Dupont AC; Largeau B; Santiago Ribeiro MJ; Guilloteau D; Tronel C; Arlicot N
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28387722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG PET/MR Imaging in Major Neurocognitive Disorders.
    Mainta IC; Perani D; Delattre BM; Assal F; Haller S; Vargas MI; Zekry DS; Frisoni GB; Zaidi H; Ratib O; Garibotto V
    Curr Alzheimer Res; 2017; 14(2):186-197. PubMed ID: 27334943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular imaging in neurological diseases].
    Reimold M; la Fougère C
    Radiologe; 2016 Jul; 56(7):580-7. PubMed ID: 27306201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular imaging by PET/SPECT].
    Ono M
    Yakugaku Zasshi; 2009 Mar; 129(3):279-87. PubMed ID: 19252385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPECT and PET radiopharmaceuticals for molecular imaging of apoptosis: from bench to clinic.
    Wang X; Feng H; Zhao S; Xu J; Wu X; Cui J; Zhang Y; Qin Y; Liu Z; Gao T; Gao Y; Zeng W
    Oncotarget; 2017 Mar; 8(12):20476-20495. PubMed ID: 28108738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging.
    Silverman DH
    J Nucl Med; 2004 Apr; 45(4):594-607. PubMed ID: 15073255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET and SPECT imaging in veterinary medicine.
    LeBlanc AK; Peremans K
    Semin Nucl Med; 2014 Jan; 44(1):47-56. PubMed ID: 24314045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nuclear medicine imaging: new radiotracers and future techniques].
    Semah F
    Neurochirurgie; 2008 May; 54(3):231-5. PubMed ID: 18440564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative evaluation on [⁹⁰Y] DOTATOC PET and SPECT imaging by phantom acquisitions and clinical applications in locoregional and systemic treatments.
    Fabbri C; Mattone V; Casi M; De Lauro F; Agostini M; Bartolini N; D'arienzo M; Marchi G; Bartolomei M; Sarti G
    Q J Nucl Med Mol Imaging; 2012 Dec; 56(6):522-8. PubMed ID: 23358405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic bone imaging in patients with prostate cancer: patient experience and acceptance of NaF-PET/CT, choline-PET/CT, whole-body MRI, and bone SPECT/CT.
    Dyrberg E; Larsen EL; Hendel HW; Thomsen HS
    Acta Radiol; 2018 Sep; 59(9):1119-1125. PubMed ID: 29313360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of Molecular Probes for Live Imaging of Cancer and Infectious Diseases].
    Fuchigami T
    Yakugaku Zasshi; 2019; 139(12):1531-1538. PubMed ID: 31787640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiopharmaceuticals in neurological and psychiatric disorders.
    Valotassiou V; Wozniak G; Sifakis N; Demakopoulos N; Georgoulias P
    Curr Clin Pharmacol; 2008 May; 3(2):99-107. PubMed ID: 18690884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Neuroimaging as a Biomarker for Neurodegenerative Diseases.
    Shimizu S; Hirose D; Hatanaka H; Takenoshita N; Kaneko Y; Ogawa Y; Sakurai H; Hanyu H
    Front Neurol; 2018; 9():265. PubMed ID: 29720959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New SPECT and PET Radiopharmaceuticals for Imaging Inflammatory Diseases: A Meta-analysis of the Last 10 Years.
    Pacilio M; Lauri C; Prosperi D; Petitti A; Signore A
    Semin Nucl Med; 2018 May; 48(3):261-276. PubMed ID: 29626943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of 201Thallium-SPECT and 18F-FDG-PET in the clinical assessment of glioma recurrence.
    Gómez-Río M; Rodríguez-Fernández A; Ramos-Font C; López-Ramírez E; Llamas-Elvira JM
    Eur J Nucl Med Mol Imaging; 2008 May; 35(5):966-75. PubMed ID: 18172642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.